chrisvoncsefalvay/vaers-outcomes huggingface dataset:
12 hours, post vax, 3rd Prevnar (given on 5/11/01), child had fever of 102F and "hives" at injection site with red linear welt, had vomited X 3 over a 2 day period of time. Came to office on Monday. Symptoms subsided.
Anxiety, swelling of left hand wrist, numbness tingling from finger tip to left bicep of injection arm.
I was diagnosed with Shingles at Patient First on 02/06/2021 following my second dosage of the Moderna vaccine on 01/25/21 . I received my first Moderna dosage on 12/28/20.  I had a rash on my left torso and stabbing like pain in my lower back and spine. I was prescibed Valacyclovir 1000mg  for 7 days . The rash progressed to painful blisters. I requested another prescription from my Nurse Practitioner, for which I took for another 5 days. The blisters were less painful and showed signs of healing by the 10th day.
Pt had complaints of swelling of the right arm with redness and warm to touch. Diagnosed with cellulitis and was treated with Doxycycline 100mg twice a day for 7 days.
ROUND LUMP/MASS DEVELOPED ANTERIOR TO THE INJECTION SITE (LEFT DELTOID)
Recently diagnosed with cardiomyopathy a couple months after vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A 47 year-old female patient received COVID-19 Vaccine - Manufacturer Unknown, (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CARDIOMYOPATHY (medically significant), outcome "unknown", described as "Recently diagnosed with cardiomyopathy a couple months after vaccine".  The lot number for COVID-19 Vaccine - Manufacturer Unknown was not provided and will be requested during follow up.
Patient reported that his arm & shoulder were very sore after he received his High Dose vaccine this year. Said it is resolving but lasted more than a couple days like his previous vaccines did.
Patient was taken to the Hospital via ambulance on April 6, 2021.  He was too weak to let to go by and requested an ambulance.  Later that night they took him to facility where there is a Cardio Lab.  While there he had a myocardial infarction and was intubated for  a week.  He was also diagnosed with pneumonia.  They inserted stents within the week while  intubated.  After he came to,   they  had him sent back to Hospital..
On 10-28-21, the patient was seen in clinic by her PCP and requested a flu vaccine. Vaccine was ordered as requested, vaccine screening checklist was completed and patient denied haviing flu vaccine yet this year, and the vaccine was administered into her left delt without any adverse event. Upon further review the following day, it was discovered the patient had actually received the same flu vaccine 2 weeks earlier on 10-14-21, but had forgotten about it.  She therefore has received 2 flu vaccines for this current flu season.
Swelling, burning, tingling, redness, pain at injection site. Patient also complained that her arm was numb. Symptoms occurs approximately 48 hours after immunization.
Injected left arm, 4/5/22, 3:56pm, no immediate reaction.....pt woke up approx 12 hours later at night, with large red welt on arm at site of injection, warm to the touch, no fever, queasy.....in morning: still queasy, red welt reduce minimally.......came to pharmacy 4 days later showed RPh, welt had reduced substantially, no fever, feeling better, etc......pt chose to wait it out will contact MD if symptoms worsen
Developed rash on right arm and below knees (bilaterally), following immunizations given. Rash is worse today that on 1/15/03 and itches. No other symptoms reported. He was ill over the weekend with sore throat and slight temperature.
On audit, patient has received multiple COVID vaccines -- Janssen x 3; Pfizer x 1. Contacted client to advise. Patient reported no ill effects.
Patient 16 years old given Moderna Booster 0.25 mL. Patient had received Pfizer series correctly 5/21/21 and 6/11/21, when arriving to clinic was slated to receive PFizer booster according to protocol. Per MA that administered - Parent asked for Moderna Vaccine and MA fulfilled request again recommendations.
This spontaneous report as received from a nurse refers to a 14 year old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 07-SEP-2017, the patient was vaccinated with improperly stored GARDASIL 9 (dosing details were not reported) (lot # N007931, expiry date: 17-NOV-2019) for prophylaxis. No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA000054.
Injection site swelling; Injection site redness; Looks like induration as well; This is a spontaneous report from a contactable nurse. A 12-month-old male patient received the forth dose of pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at 0.5 ml, single in the right thigh for standard vaccination schedule, received varicella zoster vaccine (VARICELLA VACCINE), via an unspecified route of administration on an unspecified date at unknown dose for standard vaccination schedule. There were no medical history and concomitant medications. The patient previously received three doses of pneumococcal 13-val conj vac (dipht crm197 protein) for immunization on unspecified dates. On 29Apr2019, the patient experienced injection site swelling, injection site redness, and looked like induration as well. Therapeutic measures were taken with Thlenol as a result of the events. The outcome of the events was not recovered.
Patient felt nauseas, dizzy, and faint while waiting the 15 min after the vaccine administration. We brought her back into the consult room and had her lie down. She tried throwing up, but nothing happened. After laying down for few minutes, she felt much better. Her mom came to drive her home. She was completely fine when leaving, but I will follow up with patient later this afternoon.
head splitting throbbing/headache.; This is a spontaneous report received from a contactable consumer, the patient. A 47-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) as a single dose via an unspecified route of administration in the right arm on 27Mar2021 at 16:45 (at the age of 47-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration in the right arm on 06Mar2021 (at the age of 47-years-old), as a single dose for COVID-19 immunisation. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not tested for COVID-19. On 29Mar2021, the patient experienced a head splitting throbbing headache after 35 hours of shot. The events had not resulted in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient received TYLENOL (3 x 325mg) as a treatment for the reported events. The clinical outcome of the event throbbing headache was recovered on 29Mar2021 at the time of this report. No follow-up attempts are needed. No further information is expected.
head cold; Lack of drug effect; Diagnosed with Covid; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (head cold), DRUG INEFFECTIVE (Lack of drug effect) and COVID-19 (Diagnosed with Covid) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 013AZ1A) for COVID-19 vaccination.     Concomitant products included VITAMIN B [VITAMIN B NOS], VITAMIN C [ASCORBIC ACID] and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In July 2021, the patient experienced NASOPHARYNGITIS (head cold), DRUG INEFFECTIVE (Lack of drug effect) and COVID-19 (Diagnosed with Covid). At the time of the report, NASOPHARYNGITIS (head cold), DRUG INEFFECTIVE (Lack of drug effect) and COVID-19 (Diagnosed with Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Antibody test: no antibodies (Negative) Negative. In September 2021, Antibody test: no antibodies (Negative) Negative.         Labs performed in SEP 2021 revealed that the patient had no antibodies. The test was repeated a few weeks later with the same result.  No treatment information was provided by the reporter.  This case concerns a 83-year-old female patient with no medical history reported, who experienced the unexpected events of COVID-19 and nasopharyngitis. Drug ineffective was considered as an additional event. The events occurred unknown number of days after the second dose of mRNA-1273 vaccine. The rechallenge was not applicable, as the events occurred after the second dose and no additional dosing will be given. The benefit-risk relationship of vaccine is not affected by this report. The case was assessed as non-serious based on reported seriousness and medical judgement.; Sender's Comments: This case concerns a 83-year-old female patient with no medical historyreported, who experienced the unexpected events of COVID-19 and nasopharyngitis. Drug ineffective was considered as an additional event. The events occurred unknown number of days after the second dose of mRNA-1273 vaccine. The rechallenge was not applicable, as the events occured after the second dose and no additional dosing will be given. The benefit-risk relationship of vaccine is not affected by this report. The case was assessed as non-serious based on reported seriousness and medical judgement.
*Disclaimer, all times are approximate* 6/20/21 1330: Obtained Pfizer vaccine (second dose) via injection into my left arm 6/21/21 0200 - 0700: Woke up numerous times throughout the night. At the time, I deduced that the lack of sleep attributed to rolling on the left side of my body where I felt soreness from the shot in addition to the high temperature in my condominium (this occurred during a hot, summer night and the AC was not turned on until the morning) 6/21/21 0700 - 2359: I noticed that whenever I would inhale (including breathing, laughing, yawning, coughing, etc), my lungs would feel like they were burning. Initially, I thought that I felt this way because the temperature in my condominium was higher than normal but after having the AC on all day, I realized that the burning sensation was from my lungs and not a result of the room's temperature.  6/22/21 0000 - 6/24/21 0700: The pain from inhaling persisted during this time period. I minimized the pain I felt by reducing all physical activities. Most of my day was spent either in bed or on my laptop to do remote work. During the nights, I would wake up every 30 - 60 minutes due to pain in my arm and not being able to breathe without feeling pain. 6/24/21 0700: I woke up the next morning breathing normally. I decided to get a COVID-19 test in the off-chance that I had obtained COVID-19 prior to my second Pfizer shot. Results showed that COVID-19 was not detected  Since the COVID-19 test yielded a negative result and the burning sensation during inhalation was not a listed symptom of the Pfizer vaccine, I decided to submit a report to VAERS.
Pt came in and stated that she wanted to get her 1st dose of COVID vaccine and wanted to get Moderna. After administration the pt let the pharmacist know that she had actually previously gotten both doses of Pfizer but had recently gotten a stem cell transplant and her doctor told her to redo all vaccinations and specifically to get Moderna.
Patient received Pfizer Vaccine #1 today at 0951 and was waiting her predetermined 30 minutes post vaccine secondary to history of anaphylaxis to shellfish.  At 1015 patient reported that her "throat felt funny - like it was closing."  Patient reported it was similar to when she had anaphylaxis to shellfish in the past.  Patient observed for an additional 4 minutes where she reported it was worsening.  Epi 0.3 mg SQ was given while waiting on the Rapid Response Team.
On 04/12/01, 8 1/2 hours post-immunization the patient awoke complaining of both of his thighs. The mother stayed home from work to observe. Motrin every 6 - 8 hrs, warm moist compresses to legs. The child approximately 35 lbs and very thin. Complains of inability to walk, refused to stand upright, crawling and crying. By 4PM he began using his legs. On 04/19/01, per the mother the patient is totally recovered. No more sickness.
This was my third shot, my booster due to my immune system. When I left I felt the shot go through my body unlike the prior two and instantly  my legs started to hurt. The next day I hurt so bad I didn?t want to move a hair on my body. The following day I drove around for work then started feeling chest pains, the chest pains continued and on 8-19-21  I got worried of having a heart attack and went to Hospital and they conducted several tests on me for hours and came back with nothing wrong with my heart, blood work, not covid, no blood clots, etc.  They found nothing wrong and I am continuing to have chest pains. I also have headaches and some muscle aching but the chest pains won?t stop to the point I don?t know if I?m going to make it through this. I was fine until I got this shot and with the ER doctor running me through the ringer I now am reaching out to you.
Narrative: COVID infection following COVID vaccine series 01/11, MODERNA, dose #1 (NON-CLINIC) 02/08, MODERNA, dose #2(NON-CLINIC) 12/28 COVID swab, result: detected 12/27 pt cc: chills, fatigue, fever, headache, loss of taste or smell, dyspnea exposure: unknown 12/28 pt admit ED cc: sore throat, fever, nonproductive cough dx: COVID-19 LOS: 1 day
This spontaneous report was received from a nurse and refers to a 19 year old male patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 12-AUG-2015, the patient was vaccinated with a first dose of GARDASIL 9 (dose, route of administration, anatomical location, lot# and expiration date were not reported). On 14-OCT-2015, the patient was vaccinated with a second dose of GARDASIL 9 (dose, route of administration, anatomical location, lot# and expiration date were not reported). On 12-APR-2017, the patient was vaccinated with a third dose of GARDASIL 9 lot # M044717, expiration date 19-JUL-2017 (dose, route of administration and anatomical location were not reported). No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
Patient developed inflammatory conditions after receiving second dose of Pfizer vaccine in May 2021. Developed IBS, psoriatic arthritis, and psoriasis
No Adverse Event; HCP administered a single dose of Moderna Covid-19 bivalent vail that exceeded thawing out date.Vails thaw out date expired on 5-Apr-23 administered a single dose of Moderna Covid-19 bivalent-23 vaccine was administered on and 12-Apr-23.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (HCP administered a single dose of Moderna Covid-19 bivalent vail that exceeded thawing out date.Vails thaw out date expired on 5-Apr-23 administered a single dose of Moderna Covid-19 bivalent-23 vaccine was administered on and 12-Apr-23.) and NO ADVERSE EVENT (No Adverse Event) in a 32-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 021H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Apr-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 12-Apr-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (HCP administered a single dose of Moderna Covid-19 bivalent vail that exceeded thawing out date.Vails thaw out date expired on 5-Apr-23 administered a single dose of Moderna Covid-19 bivalent-23 vaccine was administered on and 12-Apr-23.). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (HCP administered a single dose of Moderna Covid-19 bivalent vail that exceeded thawing out date.Vails thaw out date expired on 5-Apr-23 administered a single dose of Moderna Covid-19 bivalent-23 vaccine was administered on and 12-Apr-23.) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (HCP administered a single dose of Moderna Covid-19 bivalent vail that exceeded thawing out date.Vails thaw out date expired on 5-Apr-23 administered a single dose of Moderna Covid-19 bivalent-23 vaccine was administered on and 12-Apr-23.).    No concomitant information was reported. Suspect product dosage text was reported as additional booster. No treatment information was provided.
About 2 hours after Hep B vaccine given in right thigh, this NP was called to examine rash on infant's right thigh.  Right anterior thigh appeared to have scattered flat erythematous macules.  Per infant's nurse, it was unclear if this rash/lesion was present prior to vaccine administration, but parents did not notice the rash prior to vaccine.  1% Hydrocortisone ordered to the affected area per recommendation of dermatology team.   Examined the following day and the area appeared unchanged.
Hives, welts, redness, difficulty sleeping, irritated, crying, itchiness, agitated. The hives, welts, redness, and gigantic skin blotches kept appearing in different places such as ears, underarms, behind knees, ankles, foot, ears, neck, stomach, in between his inner thighs near the pens, in his buttocks area.
After taking the COVID 19 Pfizer Vaccine, I can not get out of bed because of Extreme Sensitivity of nervous system, and an Extreme Headache. After taking the COVID-19 Pfizer Vaccine, I am experiencing Extreme Headaches and extreme sensitivity of nervous system.
Information has been received from a pharmacist referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On an unknown date in November 2014 (one year ago), the patient was vaccinated with the first dose of ZOSTAVAX (lot number, expiration date, strength, dose and route were unknown). On 27-OCT-2015 the patient was vaccinated with the second dose of ZOSTAVAX (lot # L000450, expiration date 09-MAR-2016, strength, dose and route were unknown). No adverse effect reported. Additional information has been requested.
Fainted 3 times/can't stay more than 30 to 45 seconds; Need to lay on the floor/not stay for more than 30-45 seconds; Need to lay on the floor; Injection site pain; Chills; Fever; Body aches/muscle aches; Swollen lymph nodes; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of SYNCOPE (Fainted 3 times/can't stay more than 30 to 45 seconds), LETHARGY (Need to lay on the floor/not stay for more than 30-45 seconds), FATIGUE (Need to lay on the floor), VACCINATION SITE PAIN (Injection site pain), CHILLS (Chills), PYREXIA (Fever), MYALGIA (Body aches/muscle aches), LYMPHADENOPATHY (Swollen lymph nodes) and PAIN IN EXTREMITY (sore arm) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 037B21A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Seasonal allergy.   On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021 at 5:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-May-2021, the patient experienced SYNCOPE (Fainted 3 times/can't stay more than 30 to 45 seconds) (seriousness criteria disability and medically significant), FATIGUE (Need to lay on the floor) (seriousness criterion disability), VACCINATION SITE PAIN (Injection site pain) (seriousness criterion disability), CHILLS (Chills) (seriousness criterion disability), PYREXIA (Fever) (seriousness criterion disability), MYALGIA (Body aches/muscle aches) (seriousness criterion disability), LYMPHADENOPATHY (Swollen lymph nodes) (seriousness criterion disability) and PAIN IN EXTREMITY (sore arm) (seriousness criterion disability). 28-May-2021, the patient experienced LETHARGY (Need to lay on the floor/not stay for more than 30-45 seconds) (seriousness criterion disability). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) for Fever, at a dose of 0.5 dosage form. At the time of the report, SYNCOPE (Fainted 3 times/can't stay more than 30 to 45 seconds), LETHARGY (Need to lay on the floor/not stay for more than 30-45 seconds), FATIGUE (Need to lay on the floor), VACCINATION SITE PAIN (Injection site pain), CHILLS (Chills), PYREXIA (Fever), MYALGIA (Body aches/muscle aches), LYMPHADENOPATHY (Swollen lymph nodes) and PAIN IN EXTREMITY (sore arm) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-186579 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.